_
Communications Strategy
_
Progression and development of the MHRA Communication Strategy following it’s Summer 2005 introduction after publication of The "House of Commons, Health Committee’s examination into The Influence of the Pharmaceutical Industry" - initiated June 2004 - report published April 5th 2005.
_
http://www.publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/42.pdf
_
_
MHRA Communications Strategy Summer 2005- April 2007: an Agency-wide approach to communication.
__
“The MHRA is responsible for safeguarding public health by making sure that medicines and medical devices work, and are acceptably safe. If it is to be successful in this mission, the Agency must effectively communicate accurate and timely information about the benefits and risks of medicines and medical devices to key stakeholders, including the public, patients, healthcare professionals, researchers and industry.
Communications is therefore mission critical for the Agency. In 2005, the new Communications Division drew together a first communications strategy for the Agency. There have been significant improvements in the Agency’s communications through the implementation of this strategy, particularly in relation to:
- media handling, including the creation of an in-house Press Office
- website development, including the launch of a single unified website
- understanding stakeholder needs, including commissioning of detailed market research work to help us understand better the perceptions of our stakeholders
- conferences and events.”
Communications Strategy April 2007 – March 2010
_
“Our second Communications Strategy, covering the period until March 2010, briefly reviews the current situation in relation to Agency communications, and the evidence informing future development. It sets out the wider business context for communications activity, before establishing aims, priorities and actions for the three-year period.”
_
__
Patient and Public Engagement Strategy April 2009 - March 2011
_
“The MHRA has embarked on a new programme of activity to engage patients and the public in its work and the decisions it makes. The Agency’s first Patient and Public Engagement strategy, covering the period until March 2011, sets out the vision and strategic priorities in this area, and identifies a range of activities that will help build the Agency’s capacity and capability to successfully engage with patients and the public.”
_
http://www.mhra.gov.uk/home/groups/comms-sp/documents/publication/con041519.pdf
No comments:
Post a Comment